<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02195271</url>
  </required_header>
  <id_info>
    <org_study_id>130155</org_study_id>
    <nct_id>NCT02195271</nct_id>
  </id_info>
  <brief_title>Neuroplasticity:Melatonin and Transcranial Current Stimulation in Healthy Subjects.</brief_title>
  <official_title>Effect of Melatonin and Transcranial Direct Current Stimulation (tDCS) on Neuroplasticity and the Heat-pain Detection Threshold in Healthy Subjects:Randomized, Double-blind,Crossover Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain exerts a tremendous cost in healthy care, rehabilitation and lost productivity. It is is&#xD;
      associated with a wide range of diseases and their social consequences is a public health&#xD;
      problem.&#xD;
&#xD;
      With the progress of neuroscience and studies on the plasticity of the central nervous&#xD;
      system, it has been provided a better understanding of the neurobiological mechanisms of&#xD;
      pain.&#xD;
&#xD;
      The neurohormone Melatonin stands by having systemic and diverse mechanisms of action, both&#xD;
      in physiological and pathological situations, with modulating effects on the process of&#xD;
      nociceptive signaling and neurochemical mechanisms such as serotonergic, opioidergic and&#xD;
      GABAergic, exerting anti-inflammatory action, analgesic activity among others.&#xD;
&#xD;
      The advent of neuromodulation techniques such as transcranial direct current stimulation&#xD;
      (tDCS), which promote changes in neuronal activity and signaling to be effective in&#xD;
      conditions of chronic pain by attenuating changes in cortical excitability.&#xD;
&#xD;
      There is clinical evidence of the analgesic effect of Melatonin and tDCS alone. Thus,&#xD;
      considering the potential for each isolated intervention and the lack of knowledge of their&#xD;
      combined effect, the authors propose the present study to investigate the effect of this&#xD;
      combination on the heat-pain detection threshold and the neuroplasticity in the healthy&#xD;
      subjects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The methods are according to the CONSORT guidelines.&#xD;
&#xD;
      Heat pain threshold and tolerance : Quantitative Sensory Testing (QST) will be used on a&#xD;
      computer Peltier-based device thermode.&#xD;
&#xD;
      Conditioned Pain Modulation (CPM)-task: Immerssing the non-dominant hand cold water for 1&#xD;
      minute.&#xD;
&#xD;
      Serum Brain Derived Neurotrophic Factor (BDNF).&#xD;
&#xD;
      Transcranial Magnetic Stimulation (TMS) assessment: motor threshold, motor evoked potential,&#xD;
      Short intracortical inhibition and intracortical facilitation.&#xD;
&#xD;
      Statistical analyses: Descriptive statistics, Linear and multiple regression analysis,&#xD;
      performed with SPSS version18.0.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in heat-pain threshold with pain score</measure>
    <time_frame>Baseline, one week</time_frame>
    <description>Heat-threshold by Pettier-based device on the contralateral hand assessment pain score (VAS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Brain-Derived neurotrophic factor (BDNF)</measure>
    <time_frame>Baseline, one week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline from Catastrophizing Scale</measure>
    <time_frame>Baseline, one week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Inventory of state-trait anxiety Scale</measure>
    <time_frame>Baseline, one week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Inventory of Coping</measure>
    <time_frame>Baseline, one week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline of cortical excitability</measure>
    <time_frame>Baseline, one week</time_frame>
    <description>Transcranial Magnetic Stimulation (TMS) assessment motor threshold, motor-evoked potentials, silent period, intracortical inhibition and facilitation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Analgesia Disorder</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Melatonin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0,25mg/Kg sl before tDCS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcranial direct current stimulation once time. Dose 2 mA, 20 seconds.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Direct Current Stimulation (tDCS)</intervention_name>
    <arm_group_label>tDCS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <arm_group_label>Melatonin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male 18-40 years old&#xD;
&#xD;
          -  Healthy&#xD;
&#xD;
          -  Without medication&#xD;
&#xD;
          -  Sign the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who did not understand the Portuguese&#xD;
&#xD;
          -  Acute or chronic pain conditions&#xD;
&#xD;
          -  Medical or psychiatric disorders&#xD;
&#xD;
          -  History of alcohol or substance abuse&#xD;
&#xD;
          -  Neurological disorder&#xD;
&#xD;
          -  Use of medications affect in the central nervous system&#xD;
&#xD;
          -  Traumatic brain injury&#xD;
&#xD;
          -  Neurosurgery&#xD;
&#xD;
          -  Metallic implant in the brain&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolnei Caumo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Clinicas de Porto Alegre - UFRGS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wolnei Caumo, PhD</last_name>
    <phone>555133598083</phone>
    <email>caumo@cpovo.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nadia Jardim, MD</last_name>
    <phone>555133598083</phone>
    <email>nrjs@ufpa.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Clinicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>900035-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolnei Caumo</last_name>
      <phone>555133590083</phone>
      <email>caumo@cpovo.net</email>
    </contact>
    <investigator>
      <last_name>Nadia Jardim, MD, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <study_first_submitted>March 19, 2014</study_first_submitted>
  <study_first_submitted_qc>July 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2014</study_first_posted>
  <last_update_submitted>July 18, 2014</last_update_submitted>
  <last_update_submitted_qc>July 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Melatonin</keyword>
  <keyword>Transcranial Direct Current Stimulation</keyword>
  <keyword>Neuroplasticity</keyword>
  <keyword>Analgesia</keyword>
  <keyword>Pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

